Citation Impact
Citing Papers
Combining Betulinic Acid and Mithramycin A Effectively Suppresses Pancreatic Cancer by Inhibiting Proliferation, Invasion, and Angiogenesis
2011
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Endocrine Disruptors and Asthma-Associated Chemicals in Consumer Products
2012 Standout
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells
2010
Striking Oxygen Sensitivity of the Peptidylglycine α-Amidating Monooxygenase (PAM) in Neuroendocrine Cells
2015 StandoutNobel
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Constitutive Connective Tissue Growth Factor Expression in Scleroderma Fibroblasts Is Dependent on Sp1
2003
Tumor Necrosis Factor-α Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial Cells
1998
Molecular mechanisms of cereblon-based drugs
2019
Juvenile idiopathic arthritis
2007 Standout
Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway
2002 StandoutNobel
Myocardin-related Transcription Factor-A Complexes Activate Type I Collagen Expression in Lung Fibroblasts
2011
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Multiple Myeloma
2004
A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans
2004
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells
1996
Antibacterial anti-oxidant electroactive injectable hydrogel as self-healing wound dressing with hemostasis and adhesiveness for cutaneous wound healing
2017 Standout
Treatment Guidelines for HIV-Associated Wasting
2000
Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: Association with increased expression of the type I collagen gene
2000
Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis
2002
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Cancer-associated cachexia
2018 Standout
Current Therapy for Multiple Myeloma
2002
Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study
2004
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
2000 Standout
GLYCAM06: A generalizable biomolecular force field. Carbohydrates
2007 Standout
Targeted Therapy for Inherited GPI Deficiency
2007
Targeted protein degradation as a powerful research tool in basic biology and drug target discovery
2020
p53 in health and disease
2007 Standout
Sp1 Is Required for the Early Response of α2(I) Collagen to Transforming Growth Factor-β1
1997
Rat pancreatic level of cystathionine γ-lyase is regulated by glucose level via specificity protein 1 (SP1) phosphorylation
2011
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Unique features of long non-coding RNA biogenesis and function
2015 Standout
Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
2005
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
Thalidomide
2004
Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in Vivo
2003 Standout
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
2005 Standout
Synthetic approaches to the 2013 new drugs
2015
HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors
2002 StandoutNobel
CTGF expression in mesangial cells: Involvement of SMADs, MAP kinase, and PKC
2002
The 5′‐untranslated RNA of the human dhfr minor transcript alters transcription pre‐initiation complex assembly at the major (core) promoter
2002
Structure and function of “metalloantibiotics”
2003
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Treatment of Multiple Myeloma: A Comprehensive Review
2009
Chiral Toxicology: It's the Same Thing…Only Different
2009
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
Long noncoding RNAs: functional surprises from the RNA world
2009 Standout
Role of AP-1 and HIF-1 Transcription Factors in TGF-β Activation of VEGF Expression
2001
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Specificity Protein-1 as a Critical Regulator of Human Cystathionine γ-Lyase in Smooth Muscle Cells
2011
The first 30 years of p53: growing ever more complex
2009 Standout
Improved catalytic and stereoselective glycosylation with glycosyl N-trichloroacetylcarbamate: application to various 1-hydroxy sugars
2010 StandoutNobel
The thalidomide saga
2007
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Molecular Dynamics Study on the Interaction of a Mithramycin Dimer with a Decanucleotide Duplex
2005
Efficient Asymmetric Synthesis of Novel 4-Substituted and Configurationally Stable Analogues of Thalidomide
2006
TGF‐β signaling and the fibrotic response
2004 Standout
Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
2000 StandoutNobel
Peptidic degron for IMiD-induced degradation of heterologous proteins
2019 StandoutNobel
Total Synthesis of Olivomycin A
1999
Reactive oxygen species in cell signaling
2000 Standout
The constitutive photomorphogenesis 9 signalosome directs vascular endothelial growth factor production in tumor cells.
2001
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
2011
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Sp1 binding activity increases in activated Ito cells
1995
Thalidomide Pharmacokinetics and Metabolite Formation in Mice, Rabbits, and Multiple Myeloma Patients
2004
Serpinin: A Novel Chromogranin A-Derived, Secreted Peptide Up-Regulates Protease Nexin-1 Expression and Granule Biogenesis in Endocrine Cells
2011
Multiple Myeloma
2010
Transcriptional control of human p53-regulated genes
2008 Standout
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Facile Synthesis of an Azido-Labeled Thalidomide Analogue
2003
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
2004 Standout
Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome
2018
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Vascular Endothelial Cell Growth Factor–Induced Tissue Factor Expression in Endothelial Cells Is Mediated by EGR-1
1999
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Physical and Functional Sensitivity of Zinc Finger Transcription Factors to Redox Change
1996
Multiple Myeloma
2011 Standout
Sp1 and Sp3 Transcription Factors Mediate Malondialdehyde-induced Collagen α1(I) Gene Expression in Cultured Hepatic Stellate Cells
2002
Vascular endothelial growth factor (VEGF) and its receptors
1999 Standout
Epidermal growth factor increases claudin-4 expression mediated by Sp1 elevation in MDCK cells
2009
The Continuing Challenges of Leprosy
2006 Standout
Works of Steve D. Thomas being referenced
Thalidomide for the Treatment of AIDS-Associated Wasting
2000
Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo.
1991
Chiral inversion of the second generation IMiD™ CC‐4047 (ACTIMID™) in human plasma and phosphate‐buffered saline
2003
Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen?s disease patients
2000
Clinical Pharmacokinetics of Thalidomide
2004
Rapid Communication: Mithramycin Selectively Inhibits Transcription Of G-C Containing DNA
1987
Thalidomide in the treatment of leprosy
2002
S.T.E.P.S.™: A comprehensive program for controlling and monitoring access to thalidomide
1999